Sharoni R, Olivson A, Chandra M, Merin G, Uretzky G, Borman J B, Chisin R, Schwalb H, Berman E
Human Biology Research Center, Joseph Lunenfeld Cardiac Surgery Research Center, Hadassah University Hospital, Jerusalem, Israel.
Magn Reson Med. 1996 Jul;36(1):66-71. doi: 10.1002/mrm.1910360112.
Exposure to a short ischemic period (ischemic preconditioning, IP) will protect the heart from damage following a subsequent longer ischemic episode. The aim of the study was to test whether IP is cardioprotective in the setting of repeated ischemia-reperfusion cycles. Thus, Langendorff-perfused hearts, exposed to IP, were subjected to three consecutive ischemia-reperfusion (10/15 min) cycles. Myocardial energetics, manifested by 31P NMR spectroscopy, was correlated with hemodynamics. ATP recovery was significantly higher for the IP group compared with control (P < 0.02) during reperfusions. However, there was no significant difference in ATP recovery during the three ischemic intervals. The supernormal recovery of phosphocreatine recorded during reperfusion was lower for the IP group (approximately 120%) compared with control (approximately 135%, P < 0.065). Better recovery of the left ventricular-developed pressure was noted during reperfusions for the IP group and became significant only during the last reperfusion (86% versus 68%, P < 0.025). In conclusion, the above results support prolonged IP cardioprotection.
短暂缺血预处理(IP)可使心脏在随后较长时间的缺血发作后免受损伤。本研究旨在测试IP在反复缺血-再灌注循环情况下是否具有心脏保护作用。因此,对经IP处理的Langendorff灌注心脏进行三个连续的缺血-再灌注(10/15分钟)循环。通过31P核磁共振波谱显示的心肌能量代谢与血流动力学相关。再灌注期间,IP组的ATP恢复明显高于对照组(P<0.02)。然而,在三个缺血间期,ATP恢复无显著差异。与对照组(约135%,P<0.065)相比,IP组再灌注期间记录到的磷酸肌酸超常恢复较低(约120%)。IP组再灌注期间左心室舒张末压恢复较好,仅在最后一次再灌注时才显著(86%对68%,P<0.025)。总之,上述结果支持延长IP的心脏保护作用。